Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.63
-0.09 (-0.23%)
At close: Aug 15, 2025, 3:59 PM
39.20
1.46%
After-hours: Aug 15, 2025, 07:57 PM EDT

Cytokinetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-134.37M -161.38M -150.02M -160.54M -143.32M -135.64M -136.9M -129.42M -128.64M -131.29M -137.38M -142.31M -19.82M -89.44M -30.57M -76.09M -61.55M -47.1M
Depreciation & Amortization
2.29M 2.3M 2.38M 2.41M 2.41M 2.33M 6.33M 1.85M 1.85M 1.85M 1.66M 1.41M 1.41M 1.34M 734K 462K 543K 537K
Stock-Based Compensation
27.54M 23.55M 26.25M 25.36M 24.62M 21.61M 19.49M 18.72M 18.67M 15.19M 13.5M 13.18M 12.2M 8.98M 6.71M 7.77M 7.09M 5.26M
Other Working Capital
-45.66M -15.27M 52.22M 8.41M 10.74M -15.86M 35.95M 1.76M -19.8M 8.96M 1.65M 8.65M -89M -7.19M 13.28M 15.81M 15.21M 397.19M
Other Non-Cash Items
27.43M 9.11M 14.1M 21.39M 7.21M 7.89M 15.39M 11.17M 10.41M 11.13M 7.19M 31.96M 9.51M 11.82M 9.58M 11.64M 5.73M 5.43M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -23.23M n/a 1K n/a n/a n/a n/a n/a 2.84M n/a n/a n/a
Change in Working Capital
-51.11M -5.2M 41.71M 9.88M 9.77M -25.7M 44.88M 1.48M -24.1M -19.17M 16.84M 11.73M -93.77M 40.49M -34.04M 17.45M 18.69M 6.36M
Operating Cash Flow
-128.24M -131.62M -65.57M -101.5M -99.31M -129.51M -74.04M -96.2M -121.81M -122.29M -98.19M -84.04M -90.47M -26.81M -44.74M -38.77M -29.5M -29.52M
Capital Expenditures
-4.14M -5.66M -1.29M -2.46M -1.92M 1.75M -77K -220K -717K -402K -3.21M -6.33M -857K -942K -17.75M -15.7M -8.79M -6.63M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 81.33M -73.26M -82.84M -165.9M -32.45M 286.04M -66.13M n/a n/a n/a n/a n/a
Purchase of Investments
-217.97M -164.1M -121.13M -214.4M -815.24M -142.66M -226.12M -117.72M -201.59M -89.78M -125.18M -467.18M -69.91M -193.13M -31.59M -321.59M -105.66M -66.2M
Sales Maturities Of Investments
279.99M 275.73M 233.28M 170.05M 165.6M 175.3M 144.78M 190.98M 284.44M 255.68M 157.63M 181.14M 136.03M 129.79M 96.68M 128.57M 133.33M 67.55M
Other Investing Acitivies
-5M n/a n/a 1.75M n/a -1.75M -81.33M 73.26M 82.84M 165.9M 32.45M -286.04M 66.13M -63.34M 65.09M -193.02M 27.67M 1.35M
Investing Cash Flow
52.88M 105.96M 110.86M -45.05M -651.55M 32.64M -81.41M 73.04M 82.13M 165.5M 29.25M -292.37M 65.27M -64.28M 47.34M -208.72M 18.88M -5.28M
Debt Repayment
-2.7M -2.88M -2.91M -2.89M -2.88M -932K -222K -217K -212K -207K -105K 382.83M -267K -47.8M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.52M 17.54M 1.84M 3.68M -5.53M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
74.49M -13K 712.14M n/a 210.69M 11.08M 6.1M 53.12M 5.69M -6.97M 29.99M 6.19M 3.68M 141.65M 4.36M 300.89M 3.17M -3.6M
Financial Cash Flow
78.53M 4.75M 2.38M 3.42M 821.01M 103.79M 168.8M 54.22M 5.47M -7.18M 29.89M 389.02M 3.42M 93.85M 19.51M 300.89M 3.17M -3.6M
Net Cash Flow
2.5M -21.18M 47.97M -143.25M 70.17M 6.95M 13.33M 31.05M -34.2M 36.03M -39.06M 12.61M -21.79M 2.76M 22.1M 53.41M -7.44M -38.39M
Free Cash Flow
-132.38M -137.28M -66.86M -103.95M -101.23M -127.75M -74.11M -96.42M -122.52M -122.69M -101.39M -90.37M -91.33M -27.75M -62.49M -54.47M -38.29M -36.15M